SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Trump targets SentinelOne over ex-cyber chief, and the industry goes silent

Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard

Armis president sets bold goal: $1B in sales in three years, IPO in two

Ilya Sutskever’s Safe Superintelligence raises $2B at $32B valuation—with no product yet

More stories 24more

24more

Buzz

Most popular

Daily

Weekly

1

Ilya Sutskever’s Safe Superintelligence raises $2B at $32B valuation—with no product yet

2

Deel ‘spy’ avoids punishment as Irish court targets company’s CEO and legal team

3

Rafael CEO: "Iron Beam will neutralize threats at a negligible cost of less than a dollar"

4

Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive

5

Groundcover raises $35M Series B to dethrone Datadog with a new observability model

Buzzmore

Drugstore

3 stories about Drugstore

סניף של רשת החנויות סופר פארם

Israeli Drugstore Chain Super-Pharm Considering Tel Aviv IPO

12.02.19|Golan Hazani

In 2017, private equity firm CVC Capital Partners walked out on a deal to buy a 40% stake in the company at a $540 million valuation

סניף של רשת החנויות סופר פארם

Israeli Drugstore Chain Super-Pharm to Sponsor Accelerator for Retail-Focused Startups

01.01.18|Tofi Stoler

Super-Pharm partners with Tel Aviv-based accelerator SigmaLabs to launch a program for startups focused on retail experience and logistics

סניף של סופר פארם

Updated: CVC Retracts Super-Pharm Deal

04.10.17|Golan Hazani

The private equity firm was in negotiations to buy a 40% stake in drugstore chain Super-Pharm for a company value of $540 million